Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| DISCOVERY PARTNERS INTERNATIONAL INC | 90,000 | reported | 30 Mar 2022 | tx 8+425,000−75,000 |
| Lite Strategy, Inc. | 10,000 | reported | 29 Sept 2023 | tx 3+155,834 |
| Dianthus Therapeutics, Inc. /DE/ | 6,090 | reported | 21 May 2026 | tx 2+31,090 |
| ACCELERON PHARMA INC | 0 | reported | 19 Nov 2021 | tx 36+167,558−167,558 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 6,090 | 0.00 USD | deriv |
| 04 Mar 2025 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 25,000 | 0.00 USD | deriv |
| 29 Sept 2023 | GRANT_AWARD | Lite Strategy, Inc. | 10,000 | 0.00 USD | deriv |
| 05 Jul 2022 | GRANT_AWARD | Lite Strategy, Inc. | 87,500 | 0.00 USD | deriv |
| 30 Mar 2022 | GRANT_AWARD | DISCOVERY PARTNERS INTERNATIONAL INC | 90,000 | 0.00 USD | deriv |
| 22 Nov 2021 | GRANT_AWARD | Lite Strategy, Inc. | 58,334 | 0.00 USD | deriv |
| 19 Nov 2021 | TENDER | ACCELERON PHARMA INC | 18,509 | — | |
| 19 Nov 2021 | OTHER | ACCELERON PHARMA INC | 20,896 | — | deriv |
| 19 Nov 2021 | OTHER | ACCELERON PHARMA INC | 24,334 | — | deriv |
| 19 Nov 2021 | OTHER | ACCELERON PHARMA INC | 25,000 | — | deriv |
| 19 Nov 2021 | OTHER | ACCELERON PHARMA INC | 25,500 | — | deriv |
| 27 Sept 2021 | EXERCISE | ACCELERON PHARMA INC | 5,000 | 40.61 USD | |
| 27 Sept 2021 | SALE | ACCELERON PHARMA INC | 5,000 | 175.00 USD | |
| 27 Sept 2021 | EXERCISE | ACCELERON PHARMA INC | 5,000 | 0.00 USD | deriv |
| 21 Sept 2021 | EXERCISE | ACCELERON PHARMA INC | 5,000 | 40.61 USD | |
| 21 Sept 2021 | SALE | ACCELERON PHARMA INC | 5,000 | 150.03 USD | |
| 21 Sept 2021 | EXERCISE | ACCELERON PHARMA INC | 5,000 | 0.00 USD | deriv |
| 12 Feb 2021 | TAX_WITHHOLDING | ACCELERON PHARMA INC | 887 | 130.87 USD | |
| 02 Mar 2021 | SALE | ACCELERON PHARMA INC | 2,699 | 135.48 USD | |
| 02 Mar 2021 | EXERCISE | ACCELERON PHARMA INC | 5,000 | 40.61 USD | |
| 02 Mar 2021 | SALE | ACCELERON PHARMA INC | 1,501 | 136.24 USD | |
| 02 Mar 2021 | SALE | ACCELERON PHARMA INC | 200 | 138.15 USD | |
| 02 Mar 2021 | SALE | ACCELERON PHARMA INC | 600 | 137.12 USD | |
| 02 Mar 2021 | EXERCISE | ACCELERON PHARMA INC | 5,000 | 0.00 USD | deriv |
| 29 Jan 2021 | GRANT_AWARD | ACCELERON PHARMA INC | 5,409 | 0.00 USD |